Minimally invasive treatment expands options for patients with severe heart valve leakage in FloridaNaples, Fla., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Naples Comprehensive Health (NCH) has performed the ...
The FDA's approval in tricuspid regurgitation adds the clip-based Pascal Precision alongside Edwards’ Evoque implant for replacing the valve.
Recent FDA Approval of PASCAL Ace with Capture Clarity Simplifies Mitral TEER Procedures for Clinicians ...
Clinicians have been using this device to perform M-TEER for years. After this latest announcement, it is now officially ...
Medical Device Network on MSN
Edwards secures FDA approval for tricuspid valve repair system
The PASCAL Precision device is indicated to treat individuals with symptomatic severe tricuspid regurgitation.
Edwards Lifesciences ( EW) announced that the U.S. FDA has approved the PASCAL Precision System for tricuspid valve repair, providing a new treatment option for certain patients with severe tricuspid ...
Edwards said FDA approval of Pascal Ace with capture clarity simplifies mitral TEER procedures for clinicians. Edwards Lifesciences reported that FDA has approved its Pascal Precision system for ...
Edwards Lifesciences is reshaping structural heart and critical care medicine with transcatheter valves and smart monitoring tech that now set the pace for an increasingly crowded cardiovascular ...
Edwards’ approval should “strengthen the company’s position in the large and underpenetrated transcatheter tricuspid market,” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results